{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T08:25:44Z","timestamp":1762503944735},"reference-count":18,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T00:00:00Z","timestamp":1375315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["atherosclerosis-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1016\/j.atherosclerosis.2013.05.023","type":"journal-article","created":{"date-parts":[[2013,6,14]],"date-time":"2013-06-14T13:16:13Z","timestamp":1371215773000},"page":"404-407","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Statin therapy and secretory phospholipase A2 in children with heterozygous familial hypercholesterolemia"],"prefix":"10.1016","volume":"229","author":[{"given":"Marjet J.A.M.","family":"Braamskamp","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sotirios","family":"Tsimikas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Albert","family":"Wiegman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John J.P.","family":"Kastelein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara A.","family":"Hutten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.atherosclerosis.2013.05.023_bib1","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1161\/ATVBAHA.108.179705","article-title":"Inflammation in atherosclerosis","volume":"32","author":"Libby","year":"2012","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"23","key":"10.1016\/j.atherosclerosis.2013.05.023_bib2","doi-asserted-by":"crossref","first-page":"2899","DOI":"10.1093\/eurheartj\/ehs148","article-title":"Phospholipase A2 enzymes and the risk of atherosclerosis","volume":"33","author":"Rosenson","year":"2012","journal-title":"Eur Heart J"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2013.05.023_bib3","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1161\/01.ATV.0000157933.19424.b7","article-title":"Serum levels of type II secretory phospholipase A2 and the risk of future coronary artery disease in apparently healthy men and women: the EPIC-Norfolk Prospective Population Study","volume":"25","author":"Boekholdt","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"5","key":"10.1016\/j.atherosclerosis.2013.05.023_bib4","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1161\/ATVBAHA.107.139352","article-title":"Circulating secretory phospholipase A2 activity and risk of incident coronary events in healthy men and women: the EPIC-Norfolk study","volume":"27","author":"Mallat","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"9664","key":"10.1016\/j.atherosclerosis.2013.05.023_bib5","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S0140-6736(09)60403-7","article-title":"Effects of 1-H-indole-3-glyoxamide (A-002) on concentration of secretory phospholipase A2 (PLASMA study): a phase II double-blind, randomised, placebo-controlled trial","volume":"373","author":"Rosenson","year":"2009","journal-title":"Lancet"},{"issue":"1\u20132","key":"10.1016\/j.atherosclerosis.2013.05.023_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.prostaglandins.2005.10.005","article-title":"Secretory phospholipase A2 of group IIA: is it an offensive or a defensive player during atherosclerosis and other inflammatory diseases?","volume":"79","author":"Menschikowski","year":"2006","journal-title":"Prostaglandins Other Lipid Mediat"},{"issue":"12","key":"10.1016\/j.atherosclerosis.2013.05.023_bib7","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1016\/S0735-1097(02)02593-7","article-title":"Early statin therapy restores endothelial function in children with familial hypercholesterolemia","volume":"40","author":"de Jongh","year":"2002","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"9406","key":"10.1016\/j.atherosclerosis.2013.05.023_bib8","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S0140-6736(04)15467-6","article-title":"Arterial intima-media thickness in children heterozygous for familial hypercholesterolaemia","volume":"363","author":"Wiegman","year":"2004","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.atherosclerosis.2013.05.023_bib9","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1161\/ATVBAHA.107.145151","article-title":"A\u00a0systematic review and meta-analysis of statin therapy in children with familial hypercholesterolemia","volume":"27","author":"Avis","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"8","key":"10.1016\/j.atherosclerosis.2013.05.023_bib10","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1161\/CIRCULATIONAHA.111.063487","article-title":"Phospholipase A2 enzymes, high-dose atorvastatin, and prediction of ischemic events following acute coronary syndromes","volume":"125","author":"Ryu","year":"2012","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2013.05.023_bib11","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jacl.2010.11.001","article-title":"Lipoprotein-associated phospholipase A2 mass and activity in children with heterozygous familial hypercholesterolemia and unaffected siblings: effect of pravastatin","volume":"5","author":"Ryu","year":"2011","journal-title":"J\u00a0Clin Lipidol"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2013.05.023_bib12","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1001\/jama.292.3.331","article-title":"Efficacy and safety of statin therapy in children with familial hypercholesterolemia: a randomized controlled trial","volume":"292","author":"Wiegman","year":"2004","journal-title":"J Am Med Assoc"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2013.05.023_bib13","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","article-title":"Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge","volume":"18","author":"Friedewald","year":"1972","journal-title":"Clin Chem"},{"issue":"21","key":"10.1016\/j.atherosclerosis.2013.05.023_bib14","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1161\/CIRCULATIONAHA.110.936393","article-title":"Lipoprotein-associated and secreted phospholipases A in cardiovascular disease: roles as biological effectors and biomarkers","volume":"122","author":"Mallat","year":"2010","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.atherosclerosis.2013.05.023_bib15","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1161\/01.ATV.17.10.2257","article-title":"Expression of phospholipase A2 isoforms in human normal and atherosclerotic arterial wall","volume":"17","author":"Elinder","year":"1997","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"11","key":"10.1016\/j.atherosclerosis.2013.05.023_bib16","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/j.bbalip.2006.06.008","article-title":"Distinctiveness of secretory phospholipase A2 group IIA and V suggesting unique roles in atherosclerosis","volume":"1761","author":"Rosengren","year":"2006","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2013.05.023_bib17","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s10557-008-6148-1","article-title":"Future role for selective phospholipase A2 inhibitors in the prevention of atherosclerotic cardiovascular disease","volume":"23","author":"Rosenson","year":"2009","journal-title":"Cardiovasc Drugs Ther"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2013.05.023_bib18","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1097\/FJC.0b013e318195bfbc","article-title":"Varespladib (A-002), a secretory phospholipase A2 inhibitor, reduces atherosclerosis and aneurysm formation in ApoE\u2212\/\u2212 mice","volume":"53","author":"Fraser","year":"2009","journal-title":"J\u00a0Cardiovasc Pharmacol"}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915013003286?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915013003286?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,7,28]],"date-time":"2020-07-28T12:17:39Z","timestamp":1595938659000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915013003286"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8]]},"references-count":18,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,8]]}},"alternative-id":["S0021915013003286"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2013.05.023","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2013,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Statin therapy and secretory phospholipase A2 in children with heterozygous familial hypercholesterolemia","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2013.05.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}